Medicare GLP-1 Bridge: What to expect
Seeking Alpha ·
Millions of Americans are set to gain access to certain weight loss drugs through the new Medicare GLP-1 Bridge program. The pilot program will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and Dec. 31, 2027, with
DYAX Investor Sentiment
Bullish (Long) 37% · Bearish (Short) 63%
317 participants
Related News
- Investment managers exposure index jumps to highest since December
- Strategy faces legal scrutiny: MSTR under pressure, STRC hits new all-time low
- Acadia rises as EU backs Rett syndrome therapy
- RIP buybacks: The real economy returns
- Brookfield Is Quietly Building a Private Credit Powerhouse. Should Investors Take Notice?
- FDA commissioner contenders down to three - report